AN1 16.7% 0.7¢ anagenics limited

Ann: Appendix 4E and FY21 Financial Report, page-2

  1. 1,239 Posts.
    lightbulb Created with Sketch. 238
    Profit for mid year was - $2,527,788

    The first half had the adverse cash impact of Icon but was a liability in the 2020 FYE accounts hence taken up in the previous years 2020 P&L.

    Profit for FYE 2021 is - $3,386,632

    So technically they made a loss in the second half of - $858,844

    But we have to take into account the Lyramid sale and R&D $500K and $646K. So without these one off events the loss for the half is - $2,004,844

    Only a $500K improvement on the first half.

    IMO they are a long way off from profitability, sales are booked from date of invoice, not cash receipts.

    The employment costs have been discussed to abnorsiam, I'll wait to vote at the AGM and hope we get the two strikes this time.

 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $32.31K 4.617M

Buyers (Bids)

No. Vol. Price($)
2 413225 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 15.54pm 20/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.